Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

FDA announces new insulin recall due to potential labeling issue

The recall is focused on a single batch distributed from December 2021 to March 2022.

AI model able to ID early signs of type 2 diabetes on imaging results

The authors hope their findings could lead to earlier diagnoses and improvements in patient care. 

FDA announces recall of hypertension medications due to potential cancer risk

The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 

A pediatric patient who was wounded by Russian fire during fighting in Kyiv, Ukraine, being triaged at the National Children's Specialized Hospital. #Ukraine #UkraineRussianWarb #civiliancasualties

War in Ukraine: Perfusionist from Ukraine asks clinicians to help his homeland

Ukrainian native and pediatric perfusionist Kyrylo Chasovskyi is now heading efforts to mobilize funds and supplies to send to his former pediatric hospital in Kyiv.

Thumbnail

Machine learning predicts drug cardiotoxicity

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Thumbnail

Bulimia nervosa in women linked to CVD, death

Bulimia nervosa places women at a significantly greater risk of CVB and death than women who have not been diagnosed with the condition, a JAMA Psychiatry study reveals.

Thumbnail

Millennials less heart-healthy than Gen Xers at the same age

Millennials in their mid-thirties are less healthy than Generation Xers were at the same age, a recent analysis by Blue Cross Blue Shield found—a gap driven largely by poorer mental, cardiovascular and endocrine health outcomes in the younger generation.

Thumbnail

Low health literacy translates to poor medication adherence for hypertensive Hispanics

A study of more than 1,000 Hispanic adults with hypertension found increased health literacy improves patients’ adherence to blood pressure medications—but the majority of the population struggles with poor health literacy, indicating a need for tailored interventions.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.